Automated measurement of unsaturated iron binding capacity is an effective screening strategy for C282Y homozygous haemochromatosis

Gut

Volumn 46, Issue 3, 2000, Pages 405-409

  Hickman, P E ^a   Ascough, J ^a   McDonell, K ^a   Pink, A ^a   Crawford, D H G ^a   Hourigan, L F ^a   Powell, L W ^b   Cordingley, F ^a   Dimeski, G ^a   Ormiston, B ^a   Shaw, J ^a   Ferguson, W ^a   Johnson, M ^a  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Haemochromatosis; Screening; Unsaturated iron binding capacity

Indexed keywords

IRON;

ARTICLE; COST EFFECTIVENESS ANALYSIS; GENE MUTATION; GENOTYPE; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; IRON BINDING CAPACITY; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MASS SCREENING; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; COST-BENEFIT ANALYSIS; EVALUATION STUDIES; FEMALE; GENETIC MARKERS; GENETIC SCREENING; GENOTYPE; HEMOCHROMATOSIS; HUMANS; IRON; MALE; MIDDLE AGED; TRANSFERRIN;

EID: 0034027405     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.46.3.405     Document Type: Article

References (22)

1. Leggett BA, Halliday JW, Brown NN, et al. Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol 1990;74:525-30.
2. Smith BN, Kantrowitz W, Grace ND, et al. Prevalence of hereditary hemochromatosis in a Massachusetts corporation: Is Celtic origin a risk factor? Hepatology 1997; 25:1439-46.
3. Wilson JMG, Jungner G. Principles and practice of screening for disease. Public Health Papers WHO 1968;34:26-39.
4. Bassett ML, Halliday JW, Bryant S, et al. Screening for hemochromatosis. Ann NY Acad Sci 1989;526:274-8.
5. Pintar J, Skikne BS, Cook JD. A screening test for assessing iron status. Blood 1981;59:110-13.
6. Witte DL, Crosby WH, Edwards CQ, et al. Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis. Clin Chim Acta 1996;245:139-200.
7. Skikne BS, Cook JD. Screening test for iron overload. Am J Clin Nutr 1987;46:840-3.
8. Adams PC, Keretz AE, Barr R, et al. Population screening for haemochromatosis with the unbound iron capacity [abstract]. Gastroenterology 1998;114:A1199.
9. Feder JN, Gnirke A, Thomas W, et al. A novel class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399-408.
10. Jazwinska EC, Cullen LM, Busfield F, et al. Haemochromatosis and HLA-H. Nat Genet 1996;14:249-51.
11. Jouanolle AM, Gandon G, JezequeL P, et al. Haemochromatosis and HLA-H. Nat Genet 1996;14:251-2.
12. Beutler E, Gelbart T, West C, et al. Mutation analysis in hereditary hemochromatosis. Blood Cell Mol Dis 1996;22:187-94.
13. Crawford DHG, Jazwinska EC, Cullen LM, et al. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology 1998;114:1003-8.
14. Niederau C, Fischer R, Purshel A, et al. Long term survival in patients with hereditary hemochromatosis. Gastroenterology 1996;110;1107-9.
15. Salzmann P, Kerlikowske K, Phillils K. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age. Ann Intern Med 1997;27:955-65.
16. Simon B, Fletcher RH. Should all people over the age of 50 have regular fecal occult-blood tests? N Engl J Med 1998;338:1151-5.
17. Bassett ML, Leggett BA, Halliday JW, et al. Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers. J Hepatol 1997;27:517-24.
18. Shaheen NJ, Bacon BR, Grimm IS. Clinical characteristics of hereditary HC patients who lack the C282Y mutation. Hepatology 1998;28:526-9.
19. Burke W, Thomson E, Khoury MJ, et al. Hereditary hemochromatosis: Gene discovery and its implicationsfor population-based screening. JAMA 1998;280:172-8.
20. Dadone MM, Kushner JP, Edwards CQ, et al. Hereditary hemochromatosis. Analysis of laboratory expression of the diseases by genotype in 18 pedigrees. Am J Clin Pathol 1982;78:196-207.
21. McLaren CE, McLachlan GJ, Halliday JW, et al. Distribution of transferrin saturation in an Australian population: Relevance to the early diagnosis of hemochromatosis. Gastroenterology 1998;114:543-9.
22. Merryweather-Clarke AT, Pointon JJ, Shearman JD, et al. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997;34:275-8.